NEW YORK — Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion in a deal that would create a massive consumer health goods company.
NEW YORK — Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion in a deal that would create a massive consumer health goods company.


Confirmed
0
Death
0
Sign in to your account